GlassScriptPhysician profile
Deepakbabu Chellapandian
NPI 1295048452
$1,455.83
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.60 · 2021: $126 · 2022: $946 · 2023: $108 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243 · Education: $94.99 · Consulting Fee: $27.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.19 |
| Education | $94.99 |
| Consulting Fee | $27.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $1,227.60 | 2020-2024 | |
| Genetix Biotherapeutics INC | $106.19 | 2024 | |
| Adma Biomanufacturing LLC | $93.36 | 2021-2024 | |
| Astellas Pharma US INC | $28.68 | 2024 | Cresemba |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepakbabu Chellapandian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.